Evidence map›Paper›PMID 33912555›Full record

ArticleFrontiers in cell and developmental biology2021

Identification of a Novel Prognostic Signature for Gastric Cancer Based on Multiple Level Integration and Global Network Optimization.

Lin Cui, Ping Wang, Dandan Ning, Jing Shao, Guiyuan Tan, Dajian Li, Xiaoling Zhong, Wanqi Mi, Chunlong Zhang, Shizhu Jin

Abstract read
In one paragraph

Article in Frontiers in cell and developmental biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Lin CuiDepartment of Gastroenterology and Hepatology, The Second Affiliated Hospital, Harbin Medical University, Harbin, China.
Ping WangDepartment of Interventional Radiology, The Third Affiliated Hospital, Harbin Medical University, Harbin, China.
Dandan NingDepartment of Gastroenterology and Hepatology, The Second Affiliated Hospital, Harbin Medical University, Harbin, China.
Jing ShaoDepartment of Gastroenterology and Hepatology, The Second Affiliated Hospital, Harbin Medical University, Harbin, China.
Guiyuan TanCollege of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China.
Dajian LiDepartment of Gastroenterology and Hepatology, The First Hospital Of Harbin, Harbin, China.
Xiaoling ZhongCollege of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China.
Wanqi MiCollege of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China.
Chunlong ZhangCollege of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China.
Shizhu JinDepartment of Gastroenterology and Hepatology, The Second Affiliated Hospital, Harbin Medical University, Harbin, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gastric Cancer (GC) is a common cancer worldwide with a high morbidity and mortality rate in Asia. Many prognostic signatures from genes and non-coding RNA (ncRNA) levels have been identified by high-throughput expression profiling for GC. To date, there have been no reports on integrated optimization analysis based on the GC global lncRNA-miRNA-mRNA network and the prognostic mechanism has not been studied. In the present work, a Gastric Cancer specific lncRNA-miRNA-mRNA regulatory network (GCsLMM) was constructed based on the ceRNA hypothesis by combining miRNA-target interactions and data on the expression of GC. To mine for novel prognostic signatures associated with GC, we performed topological analysis, a random walk with restart algorithm, in the GCsLMM from three levels, miRNA-, mRNA-, and lncRNA-levels. We further obtained candidate prognostic signatures by calculating the integrated score and analyzed the robustness of these signatures by combination strategy. The biological roles of key candidate signatures were also explored. Finally, we targeted the PHF10 gene and analyzed the expression patterns of PHF10 in independent datasets. The findings of this study will improve our understanding of the competing endogenous RNA (ceRNA) regulatory mechanisms and further facilitate the discovery of novel prognostic biomarkers for GC clinical guidelines.

Indexed as

competing endogenous RNAsgastric cancerintegrated analysisprognostic signaturerandom walk algorithm

Identifiers

PMID33912555
PMCPMC8072341

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.